Vetsys Pharmaceutical
Kyrgyzstan’s agricultural sector, particularly the dairy industry, serves as the backbone of its rural economy. However, farmers in the region face significant challenges, including the prevalence of bovine mastitis, which severely impacts milk yield and quality. As Kyrgyzstan strives to modernize its veterinary infrastructure, the demand for high-efficacy intramammary infusions has skyrocketed.
Our solutions are engineered for this specific climate. Whether it is dry cow therapy or clinical mastitis treatment for lactating herds, Vetsys pharmaceutical solutions bridge the gap between traditional husbandry and modern veterinary science. By utilizing targeted antibiotic delivery systems, we help local farmers reduce somatic cell counts (SCC), improve milk hygiene, and secure better market prices for their dairy output.
At Zhengzhou Vetsys Pharmaceutical Co., Ltd., we have moved beyond manual production. Our "China 4.0" manufacturing facility utilizes automated assembly lines, robotic welding, and intelligent packaging systems to ensure zero-defect quality. This technological resilience allows us to offer:
Effective mastitis control in Kyrgyzstan requires a multi-faceted approach. Intramammary infusions containing Cefquinome Sulfate or the combination of Ampicillin and Cloxacillin provide a broad-spectrum shield against common pathogens like Staphylococcus aureus and Streptococcus uberis.
Pro-Tip for Local Distributors: When advising your clients, distinguish between dry cow therapy (for prevention during the dry period) and lactating cow treatments. Our product labeling and dosage protocols are explicitly designed to prevent residue issues, aligning with international export standards—essential for Kyrgyzstan's growing dairy export aspirations.
Advanced Mold Injection
Precision Welding
Automated Assembly
Quality Packaging
1. Can Vetsys customize the infusion formula for Kyrgyzstan's unique pathogen profile?
Yes. Our R&D team can collaborate with local veterinary authorities to adjust concentrations and drug combinations (e.g., Cefquinome/Gentamycin blends) to address localized resistance patterns.
2. How do you handle logistics for the Central Asian market?
We maintain a robust logistics network optimized for land transport to Kyrgyzstan. Our packaging is designed for durability during transit and seasonal temperature fluctuations.
3. Are your products GMP certified?
Absolutely. Quality is our cornerstone. Every batch undergoes rigorous quality control checks in our independent labs before shipment, ensuring full compliance with both GMP and international ISO standards.